Fig. 5From: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyConfocal analysis of systemic antibody trafficking to the CNS. Representative images from α-Syn KO, non-tg, and α-syn tg mice that were systemically injected (tail vein) with either Alexa-tagged 27-1 (control) or 1H7 antibodies and the brains were analyzed 24 h later. N = 3. Scale bar = 15 μmBack to article page